Furthermore, increased FOS mRNA in fibrotic versus non-fibrotic NAFLD patients was in line with increased EGR1 activity, which promotes FOS expression, as previously published (Table 2). Here, FOS is linked to metabolic dysfunction-associated steatotic liver disease.